A258830 Stock Overview
Sejong Medical Co., Ltd. develops, manufactures, and supplies laparoscopic surgery systems and equipment in South Korea.
Sejong Medical Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₩4,050.00|
|52 Week High||₩9,650.00|
|52 Week Low||₩1,958.00|
|1 Month Change||-3.57%|
|3 Month Change||-20.74%|
|1 Year Change||94.71%|
|3 Year Change||87.50%|
|5 Year Change||n/a|
|Change since IPO||-32.50%|
Recent News & Updates
Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively
There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...
Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year
A diverse portfolio of stocks will always have winners and losers. Of course, the aim of the game is to pick stocks...
Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?
With its stock down 7.5% over the past month, it is easy to disregard Sejong Medical (KOSDAQ:258830). We, however...
|A258830||KR Medical Equipment||KR Market|
Return vs Industry: A258830 exceeded the KR Medical Equipment industry which returned -5.8% over the past year.
Return vs Market: A258830 exceeded the KR Market which returned -14.2% over the past year.
|A258830 Average Weekly Movement||8.9%|
|Medical Equipment Industry Average Movement||5.8%|
|Market Average Movement||5.6%|
|10% most volatile stocks in KR Market||10.4%|
|10% least volatile stocks in KR Market||3.2%|
Stable Share Price: A258830 is more volatile than 75% of KR stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: A258830's weekly volatility has decreased from 15% to 9% over the past year, but is still higher than 75% of KR stocks.
About the Company
Sejong Medical Co., Ltd. develops, manufactures, and supplies laparoscopic surgery systems and equipment in South Korea. It offers trocar, single port, specimen pouch, suction irrigation, suture loop, smoke filter, BUMI, and ETC products. Sejong Medical Co., Ltd.
Sejong Medical Fundamentals Summary
|A258830 fundamental statistics|
Is A258830 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A258830 income statement (TTM)|
|Cost of Revenue||₩9.41b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-130.85|
|Net Profit Margin||-28.81%|
How did A258830 perform over the long term?See historical performance and comparison
0.5%Current Dividend Yield
Is Sejong Medical undervalued compared to its fair value and its price relative to the market?
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: A258830 (₩4050) is trading above our estimate of fair value (₩461.5)
Significantly Below Fair Value: A258830 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: A258830 is unprofitable, so we can't compare its PE Ratio to the KR Medical Equipment industry average.
PE vs Market: A258830 is unprofitable, so we can't compare its PE Ratio to the KR market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate A258830's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: A258830 is overvalued based on its PB Ratio (2.9x) compared to the KR Medical Equipment industry average (2.4x).
How is Sejong Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sejong Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Sejong Medical performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A258830 is currently unprofitable.
Growing Profit Margin: A258830 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: A258830 is unprofitable, and losses have increased over the past 5 years at a rate of 46.9% per year.
Accelerating Growth: Unable to compare A258830's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A258830 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.5%).
Return on Equity
High ROE: A258830 has a negative Return on Equity (-10.67%), as it is currently unprofitable.
How is Sejong Medical's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: A258830's short term assets (₩43.4B) exceed its short term liabilities (₩6.2B).
Long Term Liabilities: A258830's short term assets (₩43.4B) exceed its long term liabilities (₩29.5B).
Debt to Equity History and Analysis
Debt Level: A258830 has more cash than its total debt.
Reducing Debt: A258830's debt to equity ratio has increased from 13.6% to 54.6% over the past 5 years.
Debt Coverage: A258830's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A258830's interest payments on its debt are well covered by EBIT.
What is Sejong Medical current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: A258830's dividend (0.49%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (0.85%).
High Dividend: A258830's dividend (0.49%) is low compared to the top 25% of dividend payers in the KR market (2.75%).
Stability and Growth of Payments
Stable Dividend: A258830 is not paying a notable dividend for the KR market, therefore no need to check if payments are stable.
Growing Dividend: A258830 is not paying a notable dividend for the KR market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: A258830 is not paying a notable dividend for the KR market.
Cash Payout to Shareholders
Cash Flow Coverage: A258830 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Jaechul Lee is Chief Executive Officer of Sejong Medical Co., Ltd.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.9%.
Sejong Medical Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Sejong Medical Co., Ltd.
- Ticker: A258830
- Exchange: KOSDAQ
- Founded: 1996
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: ₩160.692b
- Shares outstanding: 39.68m
- Website: https://www.sejongmedical.com
Number of Employees
- Sejong Medical Co., Ltd.
- 11 Sinchon 2-ro
- South Korea
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/21 00:00|
|End of Day Share Price||2022/05/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.